PIP4K2C and neoplasm: Specifically, CSNK2A1/3 was identified as highly ranking in the P0422-T1 tumor line (Fig. 3B) and the kinases CAMKK2 and PIP4K2C were identified in the P0119-T1 CAF line (Fig. 3C).